We are live on ! Find out more
EVH icon

Evolent Health

229 hedge funds and large institutions have $1.2B invested in Evolent Health in 2025 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 82 increasing their positions, 73 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more call options, than puts

Call options by funds: $5.46M | Put options by funds: $1.66M

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

16% more capital inflows, than outflows

Capital inflows: $274M | Capital outflows: $236M

12% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 73

3.46% more ownership

Funds ownership: 105.03% → 108.49% (+3.5%)

5% less funds holding

Funds holding: 240 → 229 (-11)

17% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 53

Holders
229
Holders Change
-11
Holders Change %
-4.58%
% of All Funds
3.06%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
44
Increased
82
Reduced
73
Closed
53
Calls
$5.46​M
Puts
$1.66​M
Net Calls
+$3.8​M
Net Calls Change
-⁠$3.59​M

EVH Hedge Fund Activity: Q1 2025 in Review

229 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2025, worth a combined $1.2B — down 13% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of EVH and 44 opened new positions — a net loss of 9 holders — while 73 trimmed existing stakes and 82 added.

The largest buyer was Cadian Capital Management, adding an estimated $56.3M. The largest seller was RA Capital Management, exiting entirely with an estimated $40.2M sold.

  • 229 institutional investors held Evolent Health (EVH) as of Q1 2025, down from 240 in Q4 2024.
  • Funds reported $1.2B of Evolent Health stock for Q1 2025, down 13% quarter-over-quarter.
  • 44 funds opened new Evolent Health positions in Q1 2025 and 53 closed out, a net change of -9 holders.
  • The largest Evolent Health buyer in Q1 2025 was Cadian Capital Management, an estimated $56.3M added.
  • The largest Evolent Health seller in Q1 2025 was RA Capital Management, an estimated $40.2M sold.

Based on aggregated 13F filings for Q1 2025.